Restart Life Sciences Corp. (CSE:HEAL)

Canada flag Canada · Delayed Price · Currency is CAD
0.0500
+0.0050 (11.11%)
Apr 24, 2025, 4:00 PM EDT
-66.67%
Market Cap 1.66M
Revenue (ttm) n/a
Net Income (ttm) 224.75K
Shares Out 33.23M
EPS (ttm) 0.01
PE Ratio 5.00
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 14,000
Average Volume 38,912
Open 0.0500
Previous Close 0.0450
Day's Range 0.0500 - 0.0500
52-Week Range 0.0300 - 0.2000
Beta 0.08
RSI 40.25
Earnings Date Apr 8, 2025

About Restart Life Sciences

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing diagnostics and psilocybin-based therapeutics for the treatment of neuroinflammatory disorders, including autism spectrum disorder and fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2004
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol HEAL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.